In vivo22, 23 and in vitro studies24 of decreased or abolished mTORC1 signalling in β‐cells found reduced β‐cell mass, defective β‐cell function, hyperglycaemia and impaired glucose‐stimulated insulin secretion. The gene discussed is INS; the disease is Hyperglycemia.